Roche, Lilly Antibody Cocktails Threatened By Delta Plus Variant But More Evidence Needed

GSK Yet To Submit Application For Sotrovimab In India

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.